United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded Sep 1, 2026 · Filed Sep 2, 2026

On Sep 1, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$514.09 for US$4.88M under a trading plan, leaving 324,443 shares. Filed Sep 2, 2026 (Form 4).

Sold
9,500 shares
Price
US$514.09 average (US$510.72 to US$516.62)
Value
US$4.88M
Holding after
324,443 shares (held indirectly)
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Sep 1, 2026Common StockOption exercise9,500US$135.42333,943Indirect
Sep 1, 2026Common StockSale320US$510.72333,623Indirect
Sep 1, 2026Common StockSale825US$511.95332,798Indirect
Sep 1, 2026Common StockSale1,732US$513.12331,066Indirect
Sep 1, 2026Common StockSale3,454US$514.09327,612Indirect
Sep 1, 2026Common StockSale1,620US$514.98325,992Indirect
Sep 1, 2026Common StockSale1,469US$516.03324,523Indirect
Sep 1, 2026Common StockSale80US$516.62324,443Indirect

Source

View original at SEC

Related